Los Angeles Capital Management
NVCR icon

Los Angeles Capital Management’s NovoCure NVCR Stock Holding History

Los Angeles Capital Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-35
Closed -$449 – 2541
2025
Q4 		$449 Buy
+35
New +$449 ﹤0.01% 2492
2025
Q3 		– Sell
-33,122
Closed -$590K – 1480
2025
Q2 		$590K Sell
33,122
-22,676
-41% -$395K ﹤0.01% 807
2025
Q1 		$994K Sell
55,798
-14,803
-21% -$336K ﹤0.01% 566
2024
Q4 		$2.1M Buy
70,601
+55,334
+362% +$1.17M 0.01% 440
2024
Q3 		$239K Buy
+15,267
New +$277K ﹤0.01% 1080
2021
Q3 		– Sell
-1,529
Closed -$339K – 1557
2021
Q2 		$339K Sell
1,529
-5,829
-79% -$1.13M ﹤0.01% 1347
2021
Q1 		$973K Sell
7,358
-20,095
-73% -$3.18M ﹤0.01% 908
2020
Q4 		$4.75M Sell
27,453
-21,515
-44% -$2.94M 0.02% 405
2020
Q3 		$5.45M Sell
48,968
-145,955
-75% -$11.7M 0.03% 349
2020
Q2 		$11.6M Buy
194,923
+138,595
+246% +$9.12M 0.06% 252
2020
Q1 		$3.79M Buy
56,328
+35,545
+171% +$2.81M 0.02% 388
2019
Q4 		$1.75M Buy
20,783
+11,518
+124% +$930K 0.01% 680
2019
Q3 		$693K Sell
9,265
-12,534
-57% -$1M ﹤0.01% 904
2019
Q2 		$1.38M Buy
21,799
+500
+2% +$25.3K 0.01% 742
2019
Q1 		$1.03M Buy
+21,299
New +$1.03M 0.01% 848
2018
Q4 		– Sell
-36,244
Closed -$1.9M – 1346
2018
Q3 		$1.9M Hold
36,244
– – 0.01% 679
2018
Q2 		$1.13M Buy
+36,244
New +$1.01M 0.01% 854

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Los Angeles Capital Management's NVCR Position: Q1 2026 in Review

Los Angeles Capital Management sold out of NovoCure (NVCR) in Q1 2026, closing a stake of 35 shares — an estimated $449 sold.

Los Angeles Capital Management first reported a position in NVCR in Q2 2018 and held it in 17 quarters. The position peaked at $11.6M in Q2 2020. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Los Angeles Capital Management reported no remaining NovoCure position as of Q1 2026 after selling out during the quarter.
  • Los Angeles Capital Management sold 35 NovoCure shares in Q1 2026, an estimated $449.
  • Los Angeles Capital Management first reported a position in NovoCure in Q2 2018 and held it in 17 quarters.
  • Los Angeles Capital Management's NovoCure position peaked at $11.6M in Q2 2020.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.